1. Home
  2. YJ vs APM Comparison

YJ vs APM Comparison

Compare YJ & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YJ
  • APM
  • Stock Information
  • Founded
  • YJ 2015
  • APM 2010
  • Country
  • YJ China
  • APM United Kingdom
  • Employees
  • YJ N/A
  • APM N/A
  • Industry
  • YJ Other Specialty Stores
  • APM Biotechnology: Pharmaceutical Preparations
  • Sector
  • YJ Consumer Discretionary
  • APM Health Care
  • Exchange
  • YJ Nasdaq
  • APM Nasdaq
  • Market Cap
  • YJ 8.8M
  • APM 8.3M
  • IPO Year
  • YJ 2019
  • APM 2018
  • Fundamental
  • Price
  • YJ $1.83
  • APM $1.10
  • Analyst Decision
  • YJ
  • APM
  • Analyst Count
  • YJ 0
  • APM 0
  • Target Price
  • YJ N/A
  • APM N/A
  • AVG Volume (30 Days)
  • YJ 26.3K
  • APM 159.9K
  • Earning Date
  • YJ 03-20-2025
  • APM 12-20-2024
  • Dividend Yield
  • YJ N/A
  • APM N/A
  • EPS Growth
  • YJ N/A
  • APM N/A
  • EPS
  • YJ N/A
  • APM 0.00
  • Revenue
  • YJ $66,957,730.00
  • APM N/A
  • Revenue This Year
  • YJ N/A
  • APM $157,729.10
  • Revenue Next Year
  • YJ N/A
  • APM N/A
  • P/E Ratio
  • YJ N/A
  • APM $419.22
  • Revenue Growth
  • YJ N/A
  • APM N/A
  • 52 Week Low
  • YJ $1.42
  • APM $0.46
  • 52 Week High
  • YJ $3.84
  • APM $17.49
  • Technical
  • Relative Strength Index (RSI)
  • YJ 54.70
  • APM 45.00
  • Support Level
  • YJ $1.65
  • APM $1.02
  • Resistance Level
  • YJ $1.75
  • APM $1.80
  • Average True Range (ATR)
  • YJ 0.12
  • APM 0.14
  • MACD
  • YJ 0.00
  • APM -0.02
  • Stochastic Oscillator
  • YJ 54.55
  • APM 9.63

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in China.

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Share on Social Networks: